INTRA-CELLULAR THERAPIES, INC.
Registration details
Company overview
INTRA-CELLULAR THERAPIES, INC. is a registered legal entity registered in United States under 0451186689, and its current status with New Jersey Division of Revenue & Enterprise Services is active. The company was incorporated on 3 October 2024 and lists its registered address as Bedminster, United States. 5 shareholders are on record for INTRA-CELLULAR THERAPIES, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. Enterprise Services and was last updated on 17 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Officers
5
Registry notes and limitations
The Executive Vp, Cfo & Treasurer of INTRA-CELLULAR THERAPIES, INC. currently on record is Sanjeev Narula; five officers are currently on record for INTRA-CELLULAR THERAPIES, INC., filed with New Jersey Division of Revenue & Enterprise Services.
The register reports 10 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at INTRA-CELLULAR THERAPIES, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Johnson & Johnson
United States
How these relationships were recorded
INTRA-CELLULAR THERAPIES, INC. sits 1 level below its ultimate parent, Johnson & Johnson, registered in United States. 1 subsidiary is recorded beneath it, across 1 jurisdiction. The full chain up to Johnson & Johnson is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by INTRA-CELLULAR THERAPIES, INC.'s own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Frequently asked questions
Who owns INTRA-CELLULAR THERAPIES, INC.?
Five shareholders are currently on record for INTRA-CELLULAR THERAPIES, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is FMR, LLC, holding 17.5% — the largest recorded stake — followed by Vanguard Group Inc at 15.3%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is INTRA-CELLULAR THERAPIES, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for INTRA-CELLULAR THERAPIES, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does INTRA-CELLULAR THERAPIES, INC. have on record?
5 shareholders are shown on record for INTRA-CELLULAR THERAPIES, INC.. The register reports 20 in total; only the top 5 by holding are shown here.
What is INTRA-CELLULAR THERAPIES, INC.'s company registration number?
INTRA-CELLULAR THERAPIES, INC.'s registration number is 0451186689, filed with New Jersey Division of Revenue & Enterprise Services in United States. Its current status on the register is active.
Is INTRA-CELLULAR THERAPIES, INC. still an active company?
INTRA-CELLULAR THERAPIES, INC.'s status on New Jersey Division of Revenue & Enterprise Services is listed as active.
When was INTRA-CELLULAR THERAPIES, INC. incorporated?
INTRA-CELLULAR THERAPIES, INC. was incorporated on 3 October 2024, according to New Jersey Division of Revenue & Enterprise Services.
What is INTRA-CELLULAR THERAPIES, INC.'s registered address?
The registered address on file for INTRA-CELLULAR THERAPIES, INC. is Bedminster, United States.
Who are the officers/directors of INTRA-CELLULAR THERAPIES, INC.?
The Executive Vp, Cfo & Treasurer of INTRA-CELLULAR THERAPIES, INC. currently on record is Sanjeev Narula; five officers are currently on record for INTRA-CELLULAR THERAPIES, INC., filed with New Jersey Division of Revenue & Enterprise Services. Management authority at INTRA-CELLULAR THERAPIES, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does INTRA-CELLULAR THERAPIES, INC. have a parent company or subsidiaries?
INTRA-CELLULAR THERAPIES, INC. sits 1 level below its ultimate parent, Johnson & Johnson, registered in United States. 1 subsidiary is recorded beneath it, across 1 jurisdiction. Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.